Skip to content

Identifying interventions to improve immunization safety (4ISAFETY)

VACCINES SAFETY: EFFECT OF SUPERVISION AND SMS ON IMPROVING THE REPORTING RATE OF ADVERSE EVENTS FOLLOWING IMMUNIZATION.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201301000454298
Enrollment
440
Registered
2012-11-12
Start date
2012-12-03
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury, Occupational Diseases, Poisoning Immunization safety

Interventions

SMS
SMS and Supervision
no trial intervention

Sponsors

Cameroon Ministry of Public Health
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion and criteria At health facility level ¿ Be officially recognized and situated in a health district involved in the December 2012 meningitis immunization campaign, ¿ Have at least one health personnel, ¿ Be providing permanent health care At health personnel level ¿ Be in charge or involved in AEFI surveillance ¿ Be owner of a cell phone and subscriber of any of local telephone company ¿ Accept to be present during the intervention phase of the study period

Exclusion criteria

Exclusion criteria: Exclusion criteria At health facility level ¿ Refusal to participate of the head of the health facility, ¿ Not covered by any of local telephone company network, At health personnel level ¿ Not involved in AEFI surveillance, ¿ Be a a trainee, ¿ Target number of participants required (sample size)

Design outcomes

Primary

MeasureTime frame
AEFI reporting rate, Serious AEFI investigation rate

Secondary

MeasureTime frame
EAFI detection rate, Knowledge of health personnel on AEFI detection, reporting and investigation, Completeness of AEFI reporting form, Promptitude of AEFI reporting

Countries

Cameroon

Contacts

Public ContactLazare Kaptue

President Cameroon National Ethics Committee

prkaptue@hotmail.com00237 77 93 42 32

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026